$17.92
-1.39 (-7.20%)
Performance
1D
—
1W
-1.48%
1M
-26.92%
3M
-37.60%
6M
-27.92%
1Y
-8.38%
YTD
-23.06%
Open$18.90
Previous Close$19.31
Day High$19.42
Day Low$17.50
52W High$31.74
52W Low$17.43
Volume—
Avg Volume3.88M
Market Cap2.28B
P/E Ratio—
EPS$-3.90
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$24.26
Below
SMA 200
$24.62
Below
RSI (14)
35.3
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+460.8% upside
Current
$17.92
$17.92
Target
$100.50
$100.50
$77.00
$100.50 avg
$121.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 284.56M | 218.62M | 841.86M |
| Net Income | -406,685,200 | -281,205,193 | -67,570,170 |
| Profit Margin | -142.9% | -135.8% | -8.0% |
| EBITDA | -433,176,408 | -316,162,866 | -58,220,570 |
| Free Cash Flow | — | — | -41,442,789 |
| Rev Growth | +30.2% | +30.2% | +8.2% |
| Debt/Equity | 0.16 | 0.16 | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |